Although most other studies primarily attribute PD‐L1 expression to cancer cells, we cannot overlook the direct expression of PD‐L1 in CAFs, which may explain the differences in the efficacy of immunotherapy in some cancers. This evidence concerns the gene CD274 and cancer.